1. Home
  2. ARBK vs BOLD Comparison

ARBK vs BOLD Comparison

Compare ARBK & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARBK
  • BOLD
  • Stock Information
  • Founded
  • ARBK 2017
  • BOLD 2018
  • Country
  • ARBK United Kingdom
  • BOLD United States
  • Employees
  • ARBK N/A
  • BOLD N/A
  • Industry
  • ARBK Finance: Consumer Services
  • BOLD
  • Sector
  • ARBK Finance
  • BOLD
  • Exchange
  • ARBK Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • ARBK 21.6M
  • BOLD 24.4M
  • IPO Year
  • ARBK 2021
  • BOLD 2024
  • Fundamental
  • Price
  • ARBK $0.25
  • BOLD $1.13
  • Analyst Decision
  • ARBK Hold
  • BOLD Buy
  • Analyst Count
  • ARBK 1
  • BOLD 4
  • Target Price
  • ARBK N/A
  • BOLD $4.00
  • AVG Volume (30 Days)
  • ARBK 912.9K
  • BOLD 75.0K
  • Earning Date
  • ARBK 09-16-2025
  • BOLD 08-05-2025
  • Dividend Yield
  • ARBK N/A
  • BOLD N/A
  • EPS Growth
  • ARBK N/A
  • BOLD N/A
  • EPS
  • ARBK N/A
  • BOLD N/A
  • Revenue
  • ARBK $47,017,000.00
  • BOLD N/A
  • Revenue This Year
  • ARBK $183.90
  • BOLD N/A
  • Revenue Next Year
  • ARBK $26.78
  • BOLD N/A
  • P/E Ratio
  • ARBK N/A
  • BOLD N/A
  • Revenue Growth
  • ARBK N/A
  • BOLD N/A
  • 52 Week Low
  • ARBK $0.15
  • BOLD $1.00
  • 52 Week High
  • ARBK $1.55
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • ARBK 37.07
  • BOLD 46.56
  • Support Level
  • ARBK $0.27
  • BOLD $1.10
  • Resistance Level
  • ARBK $0.29
  • BOLD $1.16
  • Average True Range (ATR)
  • ARBK 0.02
  • BOLD 0.04
  • MACD
  • ARBK -0.00
  • BOLD -0.00
  • Stochastic Oscillator
  • ARBK 8.26
  • BOLD 40.00

About ARBK Argo Blockchain plc

Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: